Published on Friday May 05, 2023

Smooth Drug Development April 2023 News Release

We are working on the following new projects:

  • We have been awarded several bioequivalence studies by our long-term sponsor (INN: Tofisopam and Ezetimibe).
  • We have been awarded several medical documentation development projects.

We are happy to reach the following milestones in our projects:

  • The clinical part of the Lopinavir+Ritonavir study was completed.
  • 638 subjects were enrolled in the Multivitamins in Pregnant and Childbearing Women Observational Programme. 
  • 36 patients were randomised in the international phase III study of the original drug in patients with chronic myeloid leukaemia.
  • 240 subjects were randomised and 29 sites were initiated in the adezmapimod + vimdemer study for surgical adhesions.
  • 114 subjects were randomised in the Phase III study in post-COVID-19 anxiety.